Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
Open Access
Abstract
Stockpiling neuraminidase inhibitors (NAIs) such as oseltamivir and zanamivir is part of a global effort to be prepared for an influenza pandemic. However, the contribution of NAIs for the treatment and prevention of influenza and its complications is largely debatable due to constraints in the ability to control for confounders and to explore unobserved areas of the drug effects. For this study, we used a mathematical model of influenza infection which allowed transparent analyses. The model recreated the oseltamivir effects and indicated that: (i) the efficacy was limited by design, (ii) a 99% efficacy could be achieved by using high drug doses (however, taking high doses of drug 48 h post-infection could only yield a maximum of 1.6-day reduction in the time to symptom alleviation), and (iii) contributions of oseltamivir to epidemic control could be high, but were observed only in fragile settings. In a typical influenza infection, NAIs’ efficacy is inherently not high, and even if their efficacy is improved, the effect can be negligible in practice.Keywords
All Related Versions
Funding Information
- Alfons und Gertrud Kassel-Stiftung (None)
This publication has 27 references indexed in Scilit:
- Influenza treatment and prophylaxis with neuraminidase inhibitors: a reviewInfection and Drug Resistance, 2013
- Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trialBMJ, 2013
- Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in MexicoBulletin of the World Health Organization, 2012
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populationsJournal of Antimicrobial Chemotherapy, 2010
- Pharmacokinetics of High-Dose Oseltamivir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLOS Medicine, 2008
- Antiviral Resistance and the Control of Pandemic InfluenzaPLOS Medicine, 2007
- Oseltamivir Becomes Plentiful--But Still Not Cheap2006
- Avian Influenza and Pandemics — Research Needs and OpportunitiesNew England Journal of Medicine, 2005
- OseltamivirDrugs, 2001